Global Lifestyle Archives | Page 162 of 462 | Be Korea-savvy

Archive by category Global Lifestyle

Philips Continues to Demonstrate Strong Commitment to Its ESG Ambitions

Philips Continues to Demonstrate Strong Commitment to Its ESG Ambitions

Amsterdam, the Netherlands, Feb. 21 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has made strong progress towards realizing its key Environmental, Social, and Governance (ESG) ambitions. In 2022, Philips reached 1.81 billion people with its products and services, while further reducing operational emissions, and indirect (scope 3) emissions across [...]

Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study

SHANGHAI, China, Feb. 20 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced that the pre-specified interim analysis has been completed for a randomized, double-blind, placebo-controlled, multi-center phase III clinical study (“TORCHLIGHT Study”, NCT04085276) examining the company’s product toripalimab in combination with paclitaxel for injection (albumin-bound) in patients [...]

NFTE, a Global Entrepreneurship Education Nonprofit, Announces World Series of Innovation Finalists

NFTE, a Global Entrepreneurship Education Nonprofit, Announces World Series of Innovation Finalists

NEW YORK, Feb. 20 (Korea Bizwire) – Network for Teaching Entrepreneurship (NFTE) selected the top finalists in its World Series of Innovation (WSI), presented by Citi Foundation. Finalists represent the top 10 teams in each of WSI’s 10 challenge categories. WSI encourages entrepreneurship and innovation in youth ages 13 to 24, prompting them to solve global challenges in alignment [...]

Innovation Zed Announces CE Mark of New Technology InsulCheck DOSE: An Add-on Device That Automatically Logs the Time and Dialled Dosage for Insulin Pen Users

Innovation Zed Announces CE Mark of New Technology InsulCheck DOSE: An Add-on Device That Automatically Logs the Time and Dialled Dosage for Insulin Pen Users

DUBLIN, Feb. 20 (Korea Bizwire) — Innovation Zed, an Irish R&D company specialising in the design, development and manufacturing of medical technologies, announced today it has secured a CE Mark for the InsulCheck DOSE add-on device. As a leader in connected and smart drug delivery technologies, this certification showcases our commitment to meeting relevant health, [...]

Philips Recognized as Top Innovator for 10th Consecutive Year

Philips Recognized as Top Innovator for 10th Consecutive Year

Amsterdam, the Netherlands, Feb. 16 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been recognized as a Clarivate Top 100 Global Innovator™ in Clarivate Analytics’ 2023 list, which measures excellence focused on consistency and scale in innovativeness [1], thanks to its constant high performance on these metrics. [...]

Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

Junshi Biosciences and Coherus Announce Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Clinical Trial Evaluating Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

SHANGHAI, China and REDWOOD CITY, Calif., Feb. 15 (Korea Biziwire) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”) today announced positive results of a final analysis of overall survival (“OS”) from the pivotal study JUPITER-02 (NCT03581786), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab [...]